So some readers will already have seen the article in today’s New York Times entitled “Cancer’s trick for dodging the immune system“. … READ MORE …
Filed under: Uncategorized | Tagged: cure, exosome, laboratory, mice, PD-L1 | 4 Comments »
The “cure” word and its use … by oncology specialists and their patients
Posted on March 13, 2013 by Sitemaster
As many readers will be aware, the word “cure” has to be used with caution in talking about any form of cancer — prostate cancer included. While “curative” therapy can be offered to a high proportion of men diagnosed with this condition, achieving a true “cure” is a less predictable opportunity, especially for men diagnosed with intermediate- and high-risk disease. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: cancer, cure, expectation, language | 3 Comments »
New vaccine supposedly “cures prostate cancer in mice”
Posted on June 20, 2011 by Sitemaster
Now curing prostate cancer in mice absolutely does not necessarily imply that the same vaccine can be used to “cure prostate cancer in man,” … but the technical capability is certainly a step in the right direction (if it really is true). … READ MORE …
Filed under: Drugs in development | Tagged: cure, mouse, vaccine | 5 Comments »
Clinical “success” and the management of low-risk, localized prostate cancer
Posted on October 5, 2010 by Sitemaster
Historically, “success” in the treatment of localized prostate cancer was the elimination of all evidence of cancer from the patient’s prostate and other nearby tissues — through radical surgery or radiation therapy of some type. But the increasing acceptance of active surveillance and the evolution of focal forms of therapy have introduced whole new ways of thinking about the “successful” management of low- and even intermediate-risk, localized disease. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: active surveillance, control, cure, focal therapy, risk | 4 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 